Date | Gross Profit Margin | Operating Income Margin | EBT Margin | Net Income Margin |
---|
CEO | Dr. Arun Swarup Menawat MBA, Ph.D. |
IPO Date | July 10, 2018 |
Location | Canada |
Headquarters | 2400 Skymark Avenue |
Employees | 131 |
Sector | Health Care |
Industries |
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
Past 5 years
USD 0.91
USD 2.70
StockViz Staff
January 15, 2025
Any question? Send us an email